Continental Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,500
Closed -$730K 133
2015
Q4
$730K Sell
4,500
-6,500
-59% -$1.02M 0.19% 115
2015
Q3
$1.52M Sell
11,000
-12,000
-52% -$1.89M 0.41% 71
2015
Q2
$3.53M Sell
23,000
-6,000
-21% -$961K 0.94% 41
2015
Q1
$4.64M Buy
29,000
+24,000
+480% +$3.78M 1.02% 32
2014
Q4
$796K Buy
+5,000
New +$779K 0.16% 117

Other funds holding AMGN

Continental Advisors's AMGN Position: Q4 2015 in Review

Continental Advisors sold out of Amgen (AMGN) in Q4 2015, closing a stake of 2,500 shares — an estimated $393K sold.

Continental Advisors first reported a position in AMGN in Q4 2014 and held it in 3 quarters. The position peaked at $461K in Q2 2015. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Continental Advisors reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
  • Continental Advisors sold 2,500 Amgen shares in Q4 2015, an estimated $393K.
  • Continental Advisors first reported a position in Amgen in Q4 2014 and held it in 3 quarters.
  • Continental Advisors's Amgen position peaked at $461K in Q2 2015.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Continental Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.